Does molecular imaging of N-linked glycosylation suggest glycan biosynthesis is a novel target for cancer therapy?
This study suggests that NLG inhibition is a novel therapeutic strategy for targeting EGFR and RTK signaling in both gliomas and other malignant tumors.
PSI enhances TNF-alpha-induced apoptosis through inhibition of NF-kappaB activation in RGM-1 cells.